News release date: July 27, 2015
Elsevier Broadens Availability of Bentham eBooks in the fields of Medicinal Chemistry & Pharmaceutical Science
Elsevier and Bentham Science recently agreed to a distribution and co-publishing alliance, and the first titles are now available. It’s a mutually beneficial alliance. For Bentham, their chemistry titles will be distributed through Elsevier’s global sales channels, including ScienceDirect, which gives the books higher profile and growth opportunity in the global market. Elsevier benefits with immediate growth in its chemistry portfolio of books, giving researchers greater access to needed chemistry content covering pharmaceutical science, medicinal chemistry, and other multi-disciplinary topics.
The three titles recently published by and available through Elsevier are:
- Anti-Angiogenesis Drug Discovery and Development, Volume 2, edited by Atta ur-Rahman and Muhammad Iqbal Choudhary. It covers recent developments reviewed by leading experts in cancer and cardiovascular medicinal chemistry.
- Drug Design and Discovery in Alzheimer’s Disease [Frontiers in Drug Design and Discovery, Volume 6], edited by edited by Atta ur-Rahman and Muhammad Iqbal Choudhary. This book reviews developments in drug design for Alzheimer’s disease and related neurodegenerative disorders.
- Recent Advances in Medicinal Chemistry, Volume 1, edited by edited by Atta ur-Rahman, Muhammad Iqbal Choudhary, and George Perry. This book includes current research developments in pharmaceutical drug design and development.
Primary editor Atta ur-Rahman,PhD, FRS, FPAS, is a Pakistani organic chemist and a leading scientist in the field of natural product chemistry, with approximately 983 publications to his name in the field of organic chemistry. He has edited more than 40 books published by Bentham Science and Elsevier.